# Worldwide Healthcare (WWH.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Healthcare. Price 382p, market value 1.3 billionp.

## Valuation
- **P/E (trailing): 14.1×** (5-yr avg 1111.0×, 3-yr avg 1111.0×). Worldwide Healthcare trades at 14.1× trailing earnings, well below its own five-year average of 1111.0×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×.
- **Price / book: 1.0×**. The shares trade at 1.0× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -0.6%** (5-yr avg -0.0%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 7.1%**. The inverse of the P/E: 7.1% of the price is earned each year.

## Profitability
- **Gross margin: 137.1%**. Worldwide Healthcare keeps 137.1% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 157.6%**. 157.6% of revenue is left after running the business, an exceptional level.
- **Return on equity: 8.2%**. 8.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: -6.2%**. Return on all capital, debt included, is -6.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -6.7%**. Each dollar of assets produces -6.7% of profit.

## Growth
- **Revenue growth (1 yr): 106.3%** (5-yr -51.9%/yr). Revenue grew 106.3% over the last year, against -51.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 167.5%** (5-yr -19.5%/yr). Earnings per share rose 167.5%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.6×**. It would take 0.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: -8.6×**. Operating profit covers interest only -8.6×: fragile.
- **Current ratio: 6.31** (quick 6.31). Current assets cover the next year's liabilities 6.31 times.
- **Altman Z-score: 19.49**. A Z-score of 19.49 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.62%** (0p per share, trailing). Worldwide Healthcare yields 0.62%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 10%**. 10% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): -0.8%/yr** (1-yr -14.3%). The dividend has not grown over five years.
- **Shareholder yield: 43.8%**. Dividends plus net buybacks return 43.8% of the market value a year.

## Price and momentum
- **Total return (1 yr): 12.8%** (YTD 2.3%, 3-mo 10.7%). The shares are up 12.8% over twelve months including dividends.
- **From 52-week high: -8.8%** (19.2% above the low). Trading 9% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 0.52** (volatility 17%). Beta of 0.52 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=WWH.L · Page: https://foliofundamentals.com/stocks/wwh.l

Not investment advice.